Chemoprevention with aromatase inhibitors—trial strategies
- 31 December 2001
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 79 (1-5) , 143-149
- https://doi.org/10.1016/s0960-0760(01)00160-1
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Estrogen and the Risk of Breast CancerNew England Journal of Medicine, 2001
- Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialThe Lancet, 1998
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised womenThe Lancet, 1998
- Recent Trends in U.S. Breast Cancer Incidence, Survival, and Mortality RatesJNCI Journal of the National Cancer Institute, 1996
- Contralateral Primary Tumors in Breast Cancer Patients in a Randomized Trial of Adjuvant Tamoxifen TherapyJNCI Journal of the National Cancer Institute, 1991
- New Perspective on Cancer of the Contralateral Breast: A Marker for Assessing Tamoxifen as a Preventive AgentJNCI Journal of the National Cancer Institute, 1991
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- Biological Significance of Aromatase Activity in Human Breast Tumors*Journal of Clinical Endocrinology & Metabolism, 1983
- Oestradiol synthesis from C19 steroids by human breast cancersBritish Journal of Cancer, 1976